News Releases

November 23, 2020   NextCure to Present at Piper Sandler Virtual 32nd Annual Healthcare Conference

November 5, 2020   NextCure Reports Third Quarter 2020 Financial Results

September 14, 2020   NextCure Announces Appointment of John G. Houston, Ph.D., to its Board of Directors

September 8, 2020   NextCure to Present at Morgan Stanley Virtual 18th Annual Global Healthcare Conference

August 6, 2020   NextCure Reports Second Quarter 2020 Financial Results

August 5, 2020   NextCure to Present at BTIG Virtual Biotechnology Conference

July 13, 2020   NextCure Provides an Interim Update of the Phase 2 Portion of the NC318 Monotherapy Phase 1/2 Trial and Announces Departure of Chief Medical Officer

July 7, 2020   NextCure Initiates Phase 1/2 Clinical Study of NC410, a Novel Immunomedicine, for Solid Tumors

May 29, 2020   NextCure Presents Biomarker Data and Updated Clinical Results from Phase 1 Portion of its NC318 Clinical Trial at the 2020 Virtual American Society of Clinical Oncology Annual Meeting

May 7, 2020   NextCure Reports First Quarter 2020 Financial Results